Find and Pitch Jounalists, Get Your Story Covered

Tags: acute pulmonary embolism pulmonary embolism anticoagulant bleeding protamine

	Profile	Recent Articles on Subject
1	<em>The Scientist</em> Staff The Scientist Exploring Life, Inspiring Innovation. scienceinnovation	Advances in Cancer Therapies and Diagnostics - 15 days ago
2	Amir Ali, PharmD, BCOP Pharmacy Times Clinical Hem/Onc Pharmacist. USC Assistant Professor. Founder of OncologySolutionsRx. Los Angeles, CA Healthcareoncologypharmacyeducation	Emerging BCMA-Directed Therapies in Multiple Myeloma: Bispecific Antibodies and CAR T-Cell Therapies - 27 days ago
3	Angus Chen STAT News Undignified, unfunny journalist. Health, cancer coverage at STAT News. journalismhealthcancer researchSTAT News	Why bone marrow transplants are becoming less common - 29 days ago STAT+: For a leukemia that keeps returning, AbbVie drug may offer chance for a deep remission - about 1 month ago Biopharma leaders lay out vision for the future of blood cancer treatment - about 1 month ago STAT+: A targeted therapy shows it can offer a ‘last, great chance’ for some acute leukemia patients - about 1 year ago
4	Frank Vinluan MedCity News Medical innovation tracker. MedCity, USA medicalinnovation	ASH 2024 Recap: Movement in Multiple Myeloma, Cell Therapy, Sickle Cell Disease & More - about 1 month ago Artiva’s IPO Reels In $167M to Bring NK Cell Therapy to Autoimmune Diseases - 6 months ago
5	John Pinching PharmaTimes Next-gen biopharma company. La Jolla, California biopharmadrugsdevices	Cellenkos presents promising phase 1b data for CK0804 in myelofibrosis - about 1 month ago Scottish medicines consortium approves CAR T-cell therapy for blood cancer - 2 months ago Arcellx to present positive data on multiple myeloma treatments - 3 months ago Nxera and Cancer Research UK to present promising cancer drug trial at ESMO - 4 months ago
6	Meghana Keshavan STAT News Biotech nerd and writer @statnews. biotechwriting	Biopharma leaders lay out vision for the future of blood cancer treatment - about 1 month ago
7	Jonathan Wosen STAT News West Coast Biotech Reporter. Formerly @sdut. Stanford PhD. UCSC alum. San Diego, California BiotechLife SciencesImmunology	Biopharma leaders lay out vision for the future of blood cancer treatment - about 1 month ago Study paints clearer picture of disadvantaged leukemia patients’ struggle to get bone marrow transplants - about 1 month ago
8	Adam Feuerstein STAT News Reporter at STATnews. Dog lover. Polk Award winner. Boston, Massachusetts biotech reporting	Biopharma leaders lay out vision for the future of blood cancer treatment - about 1 month ago STAT+: Early data from Arcellx, Gilead suggest CAR-T for multiple myeloma could offer safety benefit - 3 months ago STAT+: Allogene to pursue new strategy for development of off-the-shelf cell therapy in blood cancer - about 1 year ago
9	Ian Ingram MedPage Today Deputy Managing Editor. MedPage Today. New York, New York medical journalismediting	Dual Targeted CAR-T Yields 99% Response Rate in Pediatric ALL - about 2 months ago FDA Approves Earlier Use of CAR-T Products for Myeloma - 10 months ago FDA Approves First CAR-T for Chronic Lymphocytic Leukemia - 10 months ago JAK1 Inhibitor Shows 'Remarkable' Activity in T-Cell Lymphoma - about 1 year ago Menin Inhibitor Yields 63% ORR in Heavily Pretreated Acute Leukemia - about 1 year ago
10	Mike Bassett MedPage Today Explains healthcare complexities. Not endorsements. New York, New York Healthcare journalism	New CAR-T Drug Induces Durable Remissions in ALL, Published Data Show - about 2 months ago Real World CAR T-Cell Therapy Outcomes 'Favorable' in Relapsed/Refractory Myeloma - 4 months ago Infections the Main Cause of Nonrelapse Mortality After CAR-T for Blood Cancers - 5 months ago FDA Greenlights First Engineered Cell Therapy for a Solid Tumor - 6 months ago PD-1 Inhibitor Plus Chemotherapy Shows Promising Activity in Rare Lymphoma - 10 months ago All-Oral Therapy Promising in Higher-Risk MDS, CMML - 12 months ago

Journalists covering acute myeloid leukemia, bone marrow, cancer, cell therapy, immunology, NK cells